Intracranial pressure (ICP) monitoring devices are used to measure the pressure inside the skull. These devices are crucial in the management of various neurological conditions, including traumatic brain injury, intracranial hemorrhage, hydrocephalus, and certain neurological infections. The global intracranial pressure monitoring devices market is expected to increase by USD 0.8 billion, at a compound annual growth rate (CAGR) of 7.2% from 2023 to 2029, according to the latest edition of the Global Intracranial Pressure Monitoring Devices Market Report.

The market for ICP monitoring devices is driven by the increasing incidence of traumatic brain injuries, the growing prevalence of neurological disorders, and the rising awareness about the importance of monitoring and managing ICP in critically ill patients. Additionally, technological advancements in these devices, such as the development of minimally invasive monitoring techniques and wireless monitoring systems, have also contributed to the growth of the market.

This comprehensive industry report provides market estimates and forecasts, accompanied by a detailed examination of the technique, application, and region aspects. It delivers a quantitative analysis of the market, empowering stakeholders to leverage existing market opportunities. Furthermore, the report identifies key segments for potential opportunities and strategies, drawing insights from market trends and the approaches of leading competitors.

The global baby bottle market has been extensively analyzed by categorizing it according to various sub-segments in order to provide accurate forecasts of industry size and assess trends within specific areas.
The global market for intracranial pressure monitoring devices can be segmented by technique: invasive, non-invasive. In 2022, the invasive segment made up the largest share of revenue generated by the intracranial pressure monitoring devices market.
Intracranial pressure monitoring devices market is further segmented by application: CSF management, electroencephalography (EEG), hydrocephalus, intracerebral hemorrhage (ICH), meningitis, migraine, stroke, subarachnoid hemorrhage (SAH), traumatic brain injury (TBI), others. The TBI segment was the largest contributor to the global intracranial pressure monitoring devices market in 2022.
Based on region, the intracranial pressure monitoring devices market is segmented into: North America, Europe, Asia-Pacific, MEA (Middle East and Africa), Latin America. North America held the highest share in the global intracranial pressure monitoring devices market. However, Asia-Pacific is forecast to register the highest CAGR during the forecast period 2023 – 2029.

The report also provides analysis of the key companies of the industry and their detailed company profiles including Integra LifeSciences Holdings Corporation, Medtronic plc, Natus Medical Incorporated, NeuraSignal, Inc., Raumedic AG, SOPHYSA SA, Spiegelberg GmbH & Co. KG, among others. In this report, key players and their strategies are thoroughly analyzed to understand the competitive outlook of the market.

Why Choose This Report

Gain a reliable outlook of the global intracranial pressure monitoring devices market forecasts from 2023 to 2029 across scenarios.
Identify growth segments for investment.
Stay ahead of competitors through company profiles and market data.
The market estimate for ease of analysis across scenarios in Excel format.
Strategy consulting and research support for three months.
Print authentication provided for the single-user license.

Market Segments Covered in Global Intracranial Pressure Monitoring Devices Industry Analysis:
i.) Technique
– Invasive
– Non-invasive

ii.) Application
– CSF management
– Electroencephalography (EEG)
– Hydrocephalus
– Intracerebral hemorrhage (ICH)
– Meningitis
– Migraine
– Stroke
– Subarachnoid hemorrhage (SAH)
– Traumatic brain injury (TBI)
– Others

iii.) Region
– North America
– Europe
– Asia-Pacific
– MEA (Middle East and Africa)
– Latin America